Arcadian Risk Capital

Arcadian Risk Capital shows how an MGA can become valuable enough for a capacity provider to monetize its equity while preserving the underwriting relationship. SiriusPoint sold its 49% stake to Lee Equity Partners for $140.4 million including a pre-close dividend, reported $17.6 million of Arcadian EBITDA and simultaneously extended capacity through 2031. The combination separates ownership from paper without severing the operating partnership. That can reduce strategic concentration for the carrier and give the MGA growth capital, but it also requires explicit governance when a former shareholder remains a major capacity provider. Terms around data access, profit commission, claims control, remediation and exit become more consequential than common ownership. Arcadian’s carrier panel now includes SiriusPoint, RenaissanceRe and Somers Re. Multiple providers can broaden product appetite and lower renewal risk, although true diversification depends on how premium, limits and collateral are allocated—not the number of names on the panel. The company operates across Bermuda, Ireland, the United Kingdom and the United States, allowing it to address global complex risks while creating a regulatory and operational coordination challenge. Its core portfolios—general liability, professional liability and property—combine long-tail casualty with large commercial property exposures. The 2026 entry into U.S. management liability extends that long-tail profile and will take years to season, making underwriting-cohort and reserve transparency essential. Property risks with total insured values generally above $1 billion add aggregation and catastrophe-management demands that differ materially from liability. Arcadian’s central test is whether a specialist underwriting culture can scale under private-equity ownership without substituting premium growth for risk selection. The indicators worth watching are accident-year loss and reserve development by class, SiriusPoint concentration and capacity economics, panel renewal and tenure, large-risk aggregation, delegated-authority exceptions, claims-control rights, new-product cohort performance, underwriter retention and how much of EBITDA reflects mature portfolios versus growth-stage business.